Beyond treatment evaluation, the HTA’s evidence-based review process has also supported major policy shifts in prevention. This includes the adoption of high-risk human papillomavirus (HrHPV) DNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results